Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can tailored rehabilitation ease common childhood illnesses in uzbekistan?

NCT ID NCT06267859

Knowledge-focused Sponsor: Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

Researchers in Uzbekistan are studying common respiratory and heart conditions in children from birth to age 15. They will analyze medical records and examine blood samples to understand immune and antioxidant function in affected children. The goal is to develop and test improved treatment and rehabilitation strategies, including adding vitamins and physiotherapy when needed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A combination of microelements and vitamins alongside physiotherapy
What this could lead to
If successful, this could lead to better, more tailored treatment and rehabilitation plans for children with common respiratory and heart conditions in Uzbekistan.
What could go wrong
This is an early-stage study focused on understanding disease patterns and developing recommendations. The added vitamins and physiotherapy are supportive, and the main outcomes are descriptive, so direct benefits to individual children are not yet established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Early phase 1

The earliest testing in people: a first look at safety, in a very small group.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Jan 2034

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 days to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * children from birth to 15 years; * children permanently residing in the territory where the clinical examination is carried out; \- children with acute bronchitis; * children included in the group of "frequently ill children"; * patients without severe chronic diseases. Exclusion Criteria: * Teenagers over 15 years old; * Patients with severe neurological and mental diseases; * Patients with endocrinological diseases; * Patients with long-term chronic somatic diseases; * Children without genetic pathologies.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute pneumonia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchitis Congenital Abnormalities congenital heart disease heart disorder lung disorder pneumonia respiratory system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Congenital heart defects Respiratory diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Turdieva Shokhida Tolkunovna

    Tashkent, Yunus-obad District, 100140, Uzbekistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.